The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration August 21, 2025 The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration
A new method developed by researchers from the Josep Carreras Institute predicts childhood hyperdiploid B-ALL relapse risk July 07, 2022 A new method developed by researchers from the Josep Carreras Institute predicts childhood hyperdiploid B-ALL relapse risk
National experts in cytogenetic diagnosis of leukemia meet at the Josep Carreras Institute to discuss the present and future of Optical Genome Mapping July 05, 2022 National experts in cytogenetic diagnosis of leukemia meet at the Josep Carreras Institute to discuss the present and future of Optical Genome Mapping
Researchers at the Josep Carreras Institute will study a rare T-cell lymphoma thanks to the Leukemia Research Foundation July 01, 2022 Researchers at the Josep Carreras Institute will study a rare T-cell lymphoma thanks to the Leukemia Research Foundation
The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program June 29, 2022 The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program
Discovered epigenetic alterations associated with the COVID-19 related severe inflammatory syndrome in childhood June 27, 2022 Discovered epigenetic alterations associated with the COVID-19 related severe inflammatory syndrome in childhood
Cancer vs. the immune system: macroH2A, a chromatin protein, can turn cancer cells deaf to immune commands June 22, 2022 Cancer vs. the immune system: macroH2A, a chromatin protein, can turn cancer cells deaf to immune commands
Genetic information from myelodysplastic syndromes’ patients incorporated in the latest update of the international standard risk assessment metric: the IPSS-M June 20, 2022 Genetic information from myelodysplastic syndromes’ patients incorporated in the latest update of the international standard risk assessment metric: the IPSS-M
Mission Bio names Josep Carreras Leukaemia Research Institute as First Center of Excellence for Tapestri Platform in Europe June 15, 2022 Mission Bio names Josep Carreras Leukaemia Research Institute as First Center of Excellence for Tapestri Platform in Europe
A new fast and reliable experimental model for vascular malformations leads to the identification of miransertib as a promising therapy option June 14, 2022 A new fast and reliable experimental model for vascular malformations leads to the identification of miransertib as a promising therapy option
A mechanism is found explaining how cancer cells turn into normal harmless ones June 09, 2022 A mechanism is found explaining how cancer cells turn into normal harmless ones
